PALE
MCID: PST092
MIFTS: 28

Posttransplant Acute Limbic Encephalitis (PALE)

Categories: Neuronal diseases, Rare diseases

Aliases & Classifications for Posttransplant Acute Limbic Encephalitis

MalaCards integrated aliases for Posttransplant Acute Limbic Encephalitis:

Name: Posttransplant Acute Limbic Encephalitis 58
Pale 58

Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Orphanet 58 ORPHA163921

Summaries for Posttransplant Acute Limbic Encephalitis

MalaCards based summary : Posttransplant Acute Limbic Encephalitis, also known as pale, is related to clear cell acanthoma and iron-refractory iron deficiency anemia. The drugs mometasone furoate and Dexlansoprazole have been mentioned in the context of this disorder. Affiliated tissues include eye, cortex and prostate.

Related Diseases for Posttransplant Acute Limbic Encephalitis

Diseases related to Posttransplant Acute Limbic Encephalitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 234)
# Related Disease Score Top Affiliating Genes
1 clear cell acanthoma 11.2
2 iron-refractory iron deficiency anemia 11.0
3 anemia, sideroblastic, 1 11.0
4 obesity, early-onset, with adrenal insufficiency and red hair 11.0
5 cardiomyopathy, infantile histiocytoid 11.0
6 tietz albinism-deafness syndrome 10.9
7 clouston syndrome 10.9
8 optic atrophy 1 10.9
9 pyruvate kinase deficiency of red cells 10.9
10 alpha-thalassemia 10.9
11 capillary malformation-arteriovenous malformation 1 10.9
12 erythroderma, ichthyosiform, congenital reticular 10.9
13 majeed syndrome 10.9
14 macular dystrophy with central cone involvement 10.9
15 paroxysmal nocturnal hemoglobinuria 10.9
16 lepromatous leprosy 10.9
17 congenital dyserythropoietic anemia 10.9
18 waardenburg's syndrome 10.9
19 hypochromic microcytic anemia with iron overload 10.9
20 methylmalonic acidemia with homocystinuria 10.9
21 deficiency anemia 10.8
22 pernicious anemia 10.8
23 oculocutaneous albinism 10.8
24 iron deficiency anemia 10.8
25 biliary atresia 10.8
26 alagille syndrome 1 10.7
27 hashimoto thyroiditis 10.7
28 klippel-trenaunay-weber syndrome 10.7
29 chromosome 5q deletion syndrome 10.7
30 motion sickness 10.7
31 noonan syndrome 1 10.7
32 optic atrophy 3, autosomal dominant 10.7
33 paget disease, extramammary 10.7
34 pheochromocytoma 10.7
35 sturge-weber syndrome 10.7
36 atransferrinemia 10.7
37 folate malabsorption, hereditary 10.7
38 glutamate formiminotransferase deficiency 10.7
39 ghosal hematodiaphyseal dysplasia 10.7
40 hemolytic uremic syndrome, atypical 1 10.7
41 thiamine-responsive megaloblastic anemia syndrome 10.7
42 myeloma, multiple 10.7
43 3-methylglutaconic aciduria, type iii 10.7
44 intrinsic factor deficiency 10.7
45 albinism, ocular, with late-onset sensorineural deafness 10.7
46 phosphoglycerate kinase 1 deficiency 10.7
47 anemia, sideroblastic, and spinocerebellar ataxia 10.7
48 spinocerebellar ataxia, x-linked 2 10.7
49 cyclic vomiting syndrome 10.7
50 pearson marrow-pancreas syndrome 10.7

Graphical network of the top 20 diseases related to Posttransplant Acute Limbic Encephalitis:



Diseases related to Posttransplant Acute Limbic Encephalitis

Symptoms & Phenotypes for Posttransplant Acute Limbic Encephalitis

Drugs & Therapeutics for Posttransplant Acute Limbic Encephalitis

Drugs for Posttransplant Acute Limbic Encephalitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 165)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
mometasone furoate Approved, Investigational, Vet_approved Phase 4 83919-23-7
2
Dexlansoprazole Approved, Investigational Phase 4 138530-94-6, 103577-45-3 9578005
3
Lansoprazole Approved, Investigational Phase 4 103577-45-3 3883
4
Methamphetamine Approved, Illicit Phase 4 537-46-2 10836
5
Lactulose Approved Phase 4 4618-18-2 11333
6
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
7
Sodium citrate Approved, Investigational Phase 4 68-04-2
8
Sorbitol Approved Phase 4 50-70-4 5780
9
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
10
Calcium carbonate Approved, Investigational Phase 4 471-34-1
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
13
Moxifloxacin Approved, Investigational Phase 4 151096-09-2, 354812-41-2 152946
14
Polyestradiol phosphate Approved Phase 4 28014-46-2
15
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
16
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
17
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
18
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
19
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
20 Opiate Alkaloids Phase 4
21 Proton Pump Inhibitors Phase 4
22 Anti-Inflammatory Agents Phase 4
23 Anti-Infective Agents Phase 4
24 Anti-Bacterial Agents Phase 4
25 Pharmaceutical Solutions Phase 4
26 Hormones Phase 4
27 Hormone Antagonists Phase 4
28 Gastrointestinal Agents Phase 4
29 Neurotransmitter Agents Phase 4
30 Antiemetics Phase 4
31 Dopamine Agents Phase 4
32 Dopamine Uptake Inhibitors Phase 4
33 Central Nervous System Stimulants Phase 4
34 Sympathomimetics Phase 4
35 Adrenergic Agents Phase 4
36 Citrate Phase 4
37 Anti-Ulcer Agents Phase 4
38 Antacids Phase 4
39 Antineoplastic Agents, Hormonal Phase 4
40 Cathartics Phase 4
41 Anti-HIV Agents Phase 4
42 Reverse Transcriptase Inhibitors Phase 4
43 Anti-Retroviral Agents Phase 4
44 Laxatives Phase 4
45 Dextrans Phase 4
46 Vaccines Phase 4
47 Calcium, Dietary Phase 4
48 Immunologic Factors Phase 4
49 Immunosuppressive Agents Phase 4
50 Contraceptive Agents Phase 4

Interventional clinical trials:

(show top 50) (show all 62)
# Name Status NCT ID Phase Drugs
1 Naproxen for Acute Pain After Surgery: A Randomized, Placebo-Controlled Trial Unknown status NCT00615875 Phase 4 naproxen;placebo
2 The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored Turbinate. A Randomized Controlled Trial Unknown status NCT02278081 Phase 4 lansoprazole;placebo
3 A Phase IV Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral Digital Subtraction Angiography (DSA) Completed NCT00740207 Phase 4 VISIPAQUE 270;Isovue 250
4 Blood Glucose Response After Oral Intake of Lactulose (Laevolac®) in Mildly Constipated Patients With Diabetes Mellitus Type 2 Completed NCT03666546 Phase 4 Lactulose crystals 20 g;Lactulose crystals 30 g;Lactulose liquid 20 g;Lactulose liquid 30 g;Glucose;Still water
5 An Open-label Single-Center, 4-Period William's Cross-Over Design Drug Interaction Trial to Determine the Effects of Sorbitol-Containing Solutions on Lamivudine Exposure Following Administration of Lamivudine Oral Solution in Healthy Adult Subjects Completed NCT02634073 Phase 4 Lamivudine;Sorbitol
6 Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules With RotaTeq® and Rotarix® Completed NCT01266850 Phase 4
7 An Evaluation of the Immune Response to Pentavalent Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
8 A Two Different Chemoprophylaxis Approaches After Phacoemulsification Surgery in One Thousand Patients in Iraq :a Clinical Trial Completed NCT03634852 Phase 4 Moxifloxacin hydrochloride 0.5% eye drops;Dexamethasone 0.1% eye drops;Intracameral Moxifloxacin 0.1%;Subconjunctival Triamcinolone acetonide 4 mg /0.4 ml
9 Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients:A Multicentre Randomized Double-Blind Trail of Contrast-Induced Nephropathy in Patients With Chronic Kidney Disease Terminated NCT01402219 Phase 4 Iopamidol injection 76%;iodixanol
10 RECARE (REnal Safety Following the Intra-Arterial Administration of Iopamidol vs. Iodixanol During Coronary AngiogRaphy in DiabEtic Patients) Terminated NCT00782639 Phase 4 Iopamidol injection 76%;iodixanol
11 Irinotecan-Eluting Bead (DEBIRI) for Unresectable Liver Metastases From Colorectal Cancer After Systemic Chemotherapy Failure Unknown status NCT03175016 Phase 2, Phase 3 Irinotecan
12 An Open Label, Randomised, Three Arm, Single Dose, Multicentre, Parallel Group Study in Healthy Subjects to Compare the Pharmacokinetics of Subcutaneous Mepolizumab When Delivered as a Liquid Drug Product in a Safety Syringe or an Auto Injector With a Reconstituted Lyophilised Drug Product From a Vial Completed NCT03014674 Phase 3
13 A Randomised, Double-blind, Parallel Group PhIII Study to Assess the Clinical Efficacy and Safety of 100 mg SC Mepolizumab as an Add on to Maintenance Treatment in Adults With Severe Bilateral Nasal Polyps - SYNAPSE (StudY in NAsal Polyps Patients to Assess the Safety and Efficacy of Mepolizumab) Completed NCT03085797 Phase 3 Mepolizumab;Placebo;Mometasone furoate
14 A 52-week, Phase III, Open-label, Multi-center Study to Evaluate Efficacy and Safety of GSK1278863 in Japanese Non-dialysis and Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease Completed NCT02791763 Phase 3 1 to 4 mg tablets of GSK1278863;6 mg GSK1278863 tablet;Epoetin beta pegol
15 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of an Autoinjector for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 204959) Completed NCT03099096 Phase 3 Mepolizumab
16 Open Label, Phase III Safety, Efficacy, and Pharmacokinetic Study of NABI-IGIV 10% [Immune Globulin Intravenous (Human), 10%] in Subjects With Primary Immune Deficiency Disorders (PIDD) Completed NCT00538915 Phase 3
17 An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667) Completed NCT03021304 Phase 3 Mepolizumab
18 A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib Recruiting NCT03459534 Phase 3 Radotinib HCl
19 A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease Active, not recruiting NCT02697734 Phase 3 osilodrostat;osilodrostat Placebo
20 Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD) Completed NCT02702817 Phase 2 Naproxen;Placebo
21 A Phase II, Randomized, Two-Part, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Safety, Tolerability, and Efficacy of GSK2140944 in the Treatment of Subjects With Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections Completed NCT02045797 Phase 2 GSK2140944 Lyophile;GSK2140944 Capsules
22 Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers Completed NCT00066066 Phase 2 Metronidazole;Amoxicillin;Doxycycline
23 Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer Completed NCT02015754 Phase 2 DEBIRI
24 An Open-Label, Phase II, Study to Evaluate Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer Receiving Treatment With Trastuzumab in Combination With Lapatinib or Chemotherapy (EGF117165) Completed NCT02213042 Phase 2 Lapatinib
25 A Phase II, Randomized, Multicenter, Dose-Ranging Study in Adult Subjects Evaluating the Efficacy, Safety, and Tolerability of Single Doses of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae Completed NCT02294682 Phase 2 GSK2140944
26 A Randomized Phase II Study Comparing Bipolar Androgen Therapy vs. Enzalutamide in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Completed NCT02286921 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone Enanthate
27 A Multi-Centre, Randomized, Double-Blind, Placebo-Controlled, Repeat-Dose Study to Evaluate the Efficacy and Safety of Intravenous GSK679586 in Patients With Severe Asthma Completed NCT00843193 Phase 2 INTRAVENOUS GSK679586;INTRAVENOUS PLACEBO;FLUTICASONE PROPIONATE
28 A Randomized Phase II Study Comparing Sequential High Dose Testosterone and Enzalutamide to Enzalutamide Alone in Asymptomatic Men With Castration Resistant Metastatic Prostate Cancer Recruiting NCT04363164 Phase 2 Testosterone cypionate;Enzalutamide;Testosterone enanthate
29 Interferon Lambda for Immediate Antiviral Therapy at Diagnosis (ILIAD): A Phase II Randomized, Double-blind, Placebo-controlled, Multicenter Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 Recruiting NCT04354259 Phase 2 Peginterferon Lambda-1A
30 A Phase II Study to Determine Sequential Response to Bipolar Androgen Therapy (BAT) Followed by Enzalutamide or Abiraterone Post-BAT in Men With Prostate Cancer Progressing on Combined Androgen Ablative Therapies Recruiting NCT02090114 Phase 2 Testosterone cypionate;Testosterone Enanthate;Abiraterone acetate (Cohort B = CLOSED TO ACCRUAL);Enzalutamide (Cohort A = CLOSED TO ACCRUAL)
31 High Dose Testosterone in Men With Advanced Prostate Cancer and Homologous Recombination Deficiency Recruiting NCT03522064 Phase 2 Testosterone Enanthate
32 A Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602). Active, not recruiting NCT03177239 Phase 2 Nivolumab;Ipilimumab
33 COMbination of Bipolar Androgen Therapy and Nivolumab in Patients With Metastatic Castration-Resistant Prostate Cancer Active, not recruiting NCT03554317 Phase 2 Testosterone cypionate;Nivolumab
34 Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis: A Randomized Control Trial Enrolling by invitation NCT04130451 Phase 1, Phase 2 PYODINE AND TALC SLURRY
35 A Randomised, Double-blind, Placebo-controlled, Phase 2 Evaluation of the Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy Not yet recruiting NCT04706429 Phase 2 Trientine;Placebo
36 Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients Terminated NCT01808261 Phase 2 GSK249320 100/mg;Placebo
37 A Phase II Study of Irinotecan HCI in Patients With Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas Terminated NCT00360828 Phase 2 Irinotecan Hydrochloride (HCI) Treatment;Continued Irinotecan Hydrochloride (HCI) Treatment
38 A Single-centre, Open Single-arm Study Where the Safety, Tolerability and Efficacy of Subcutaneously Administered ILB Will be Evaluated in Patients With Amyotrophic Lateral Sclerosis Terminated NCT03613571 Phase 2 ILB
39 A Placebo Controlled, Double-blind, Multi-centre, Single Dose, Parallel Group, Randomised Clinical Trial of GSK2862277 in Patients Undergoing Oesophagectomy Surgery Terminated NCT02221037 Phase 2 GSK2862277;Placebo
40 A Two Part Phase IIa Study, to Evaluate the Safety and Tolerability, Pharmacokinetics, Proof of Mechanism and Potential for Efficacy of an Anti-IL-7 Receptor-α Monoclonal Antibody (GSK2618960) in the Treatment of Primary Sjögren's Syndrome Withdrawn NCT03239600 Phase 2 GSK2618960 2 mg/kg;Placebo;Methotrexate
41 An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666) Completed NCT01934205 Phase 1 GSK2140944 (Single dose);GSK2140944 (Multiple dose)
42 A Phase I, Randomized, Double-Blind Study to Assess the Effects of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of Repeat Oral Dosing of Casopitant in Healthy Subjects Completed NCT00460707 Phase 1 Casopitant 150 mg;Ketoconazole;Casopitant 150 mg matching placebo;Casopitant 50 mg;Casopitant 50 mg matching placebo
43 A Phase I, Double-blind, Randomized, Placebo Controlled, Dose Escalation Study of Valortim® (MDX-1303) Administered Intravenously (IV) as a 120 Minute Infusion in Healthy, Normal Subjects Completed NCT01265745 Phase 1 Normal Saline for Injection
44 A Phase I; Multi-Center; Open-Label (Parts 1 and 2); Randomized, Double-Blind, Placebo-Controlled (Part 3); Single-Dose; 3-Part Study to Evaluate the Relative Bioavailability of Three Formulations in Healthy Subjects, Food Effect on Tablet Formulation in Healthy Subjects, and Pharmacokinetics of Gepotidacin (GSK2140944) in Japanese Subjects in Fasted and Fed States Completed NCT02853435 Phase 1 Gepotidacin RC Tablet;Gepotidacin HSWG Tablet;Gepotidacin Capsule
45 An Open-label Balanced, Randomised, Single Dose, Two-way Crossover Study to Determine the Bioequivalence of GW483100 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) Relative to Reference Montelukast Sodium 10 mg Tablets (Containing Montelukast Sodium Equivalent to 10 mg of Montelukast) in Healthy Male and Female Volunteers Under Fasting Conditions Completed NCT02658422 Phase 1 Test Montelukast;Reference Montelukast
46 A Single/Repeat Dose Study With Three Oral Formulations of Firategrast (Immediate Release Tablet, Modified Release Tablet, and Naso-gastric Infusion) in Healthy Male Volunteers Completed NCT01416363 Phase 1 Firategrast immediate release tablet;Firategrast modified release tablet;Firategrast gastro-retentive solution
47 A Pilot Study in Healthy Male Volunteers to Evaluate a Skeletal-Muscle Microbiopsy Technique for Suitability of Use With Dynamic Proteomic Measurement Completed NCT01962454 Phase 1 Deuterated Water;Testosterone enanthate;Placebo to match testosterone enanthate
48 Multi-arm, Non-randomized, Open-Label Phase IB Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated FGF Pathway Signaling Completed NCT01868022 Phase 1 GSK3052230;paclitaxel;carboplatin;docetaxel;pemetrexed;cisplatin
49 A Phase I Randomized Study in Healthy Adults to Assess the Safety, Reactogenicity and Immunogenicity of Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine Completed NCT02251288 Phase 1 MF59 adjuvant
50 A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, 4-Period Crossover Study to Evaluate the Effect of GSK2140944 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers Completed NCT02257398 Phase 1 GSK2140944;GSK2140944 placebo;Moxifloxacin;Moxifloxacin placebo

Search NIH Clinical Center for Posttransplant Acute Limbic Encephalitis

Genetic Tests for Posttransplant Acute Limbic Encephalitis

Anatomical Context for Posttransplant Acute Limbic Encephalitis

MalaCards organs/tissues related to Posttransplant Acute Limbic Encephalitis:

40
Eye, Cortex, Prostate, Skeletal Muscle, Bone Marrow, Pancreas, Tongue

Publications for Posttransplant Acute Limbic Encephalitis

Articles related to Posttransplant Acute Limbic Encephalitis:

(show top 50) (show all 8702)
# Title Authors PMID Year
1
Temperature-dependent in vitro digestion properties of isoelectric solubilization/precipitation (ISP)-isolated PSE-like chicken protein. 61
33158684 2021
2
Discrimination of honey and syrup-based adulteration by mineral element chemometrics profiling. 61
33129616 2021
3
Characterization of the Pale Yellow Petal/Xanthophyll Esterase gene family in citrus as candidates for carotenoid esterification in fruits. 61
33092926 2021
4
Effects of pulsed electric fields on the conformation and gelation properties of myofibrillar proteins isolated from pale, soft, exudative (PSE)-like chicken breast meat: A molecular dynamics study. 61
33069524 2021
5
First record of the genus Hennegoides Lom, Tonguthai and Dyková, 1991 from Punjab (India) infecting the catfish, Sperata seenghala (Sykes, 1839). 61
33364159 2021
6
Excitation-emission matrix fluorescence spectroscopy coupled with multi-way chemometric techniques for characterization and classification of Chinese lager beers. 61
33051102 2021
7
Milk of calcium pericardial effusion confirmed with postmortem computed tomography and autopsy findings: A case report. 61
33429330 2021
8
A multi-responsive pyranone based Schiff base for the selective, sensitive and competent recognition of copper metal ions. 61
33257246 2021
9
Estimation of the stability of skeletal muscle myoglobin of chilled pork treated with brine activated by low-frequency high-intensity ultrasound. 61
33125961 2021
10
Novel microencapsulated yeast for the primary fermentation of green beer: kinetic behavior, volatiles and sensory profile. 61
32871359 2021
11
Synthesis of Multi-Functional Carbon Quantum Dots for Targeted Antitumor Therapy. 61
33389420 2021
12
Chagas disease in urban and peri-urban environment in the Amazon: sentinel hosts, vectors, and the environment. 61
33582143 2021
13
Value of the International Classification of Diseases code for identifying children with biliary atresia. 61
32882783 2021
14
Hyaline Inclusion Acanthoma. 61
33606370 2021
15
Autopsy case of Rosai-Dorfman disease presenting as fibrinous pericarditis. 61
33227653 2021
16
Development of neovascular glaucoma after intraocular surgery in Pierson syndrome. 61
33554690 2021
17
Dysgerminoma of the Ovary: An Analysis of 140 Cases Emphasizing Unusual Microscopic Findings and Resultant Diagnostic Problems. 61
33577182 2021
18
Müllerian Mucinous Cystadenomas of the Ovary: A Report of 25 Cases of an Unheralded Benign Ovarian Neoplasm Often Associated With Endometriosis and a Brief Consideration of Neoplasms Arising From the Latter. 61
33577227 2021
19
A case of Trypanosoma evansi in a German Shepherd dog in Vietnam. 61
32931934 2021
20
Nutrient Imbalance of the Host Plant for Larvae of the Pale Grass Blue Butterfly May Mediate the Field Effect of Low-Dose Radiation Exposure in Fukushima: Dose-Dependent Changes in the Sodium Content. 61
33572324 2021
21
Multilocus phylogeny of African striped grass mice (Lemniscomys): Stripe pattern only partly reflects evolutionary relationships. 61
33160039 2021
22
Controlled Photoinduced Generation of "Visual" Partially and Fully Charge Separated States in Viologen Analogues. 61
33522242 2021
23
Hemochromatosis, alcoholism and unhealthy dietary fat: a case report. 61
33596964 2021
24
[Clinicopathological analysis of clear cell renal cell carcinoma with hemangioblastoma component]. 61
33535303 2021
25
Fast T-Type Photochromism of Colloidal Cu-Doped ZnS Nanocrystals. 61
33430582 2021
26
Gross, microscopic, radiologic, echocardiographic and haematological findings in rats experimentally infected with Angiostrongylus cantonensis. 61
32741388 2021
27
Intense bloom of the diatom Hemidiscus hardmanianus (Greville) in relation to water quality and plankton communities in Tuticorin coast, Gulf of Mannar, India. 61
33272587 2021
28
First Report of Leaf Blight Caused by Limonomyces roseipellis on Maize (Zea mays L) in China. 61
33560884 2021
29
First report of root rot on Dendrobium officinale caused by Fusarium incarnatum-equiseti species complex in Zhejiang Province, China. 61
33591829 2021
30
From 1D to 3D: Perovskites within the System HSC(NH2)2I/CH3NH3I/PbI2 with Maintenance of the Cubic Closest Packing. 61
33595298 2021
31
A rare postoperative complication after a step-up approach for walled-off pancreatic necrosis: locating a difficult digestive duct fistula. 61
33228370 2021
32
Flaviaesturariibacter aridisoli sp. nov., A Bacterium Isolated from Dry Soil. 61
33392675 2021
33
Effect of meat temperature on moisture loss, water properties, and protein profiles of broiler pectoralis major with the woody breast condition. 61
33518085 2021
34
Spirosoma taeanense sp. nov., a radiation resistant bacterium isolated from a coastal sand dune. 61
33449223 2021
35
First Report of Fusarium equiseti Causing Seedling Death on Sugar Beet in Minnesota, USA. 61
33599518 2021
36
First Report of Colletotrichum brevisporum Causing Anthracnose of Dalbergia odorifera in China. 61
33529068 2021
37
Hop stunt viroid: A polyphagous pathogenic RNA that has shed light on viroid-host interactions. 61
33305492 2021
38
High expression of BCL6 inhibits the differentiation and development of hematopoietic stem cells and affects the growth and development of chickens. 61
33541426 2021
39
Histologic changes caused by injection of a novel submucosal lifting agent for endoscopic resection in GI lesions. 61
32593688 2021
40
Identification of a candidate genetic variant for the Himalayan color pattern in dogs. 61
33039541 2021
41
First report of Fusarium incarnatum causing fruit rot of litchi in China. 61
33529072 2021
42
Histological, histochemical, immunohistochemical and ultrastructural characterization of the testes of the dove. 61
32880251 2021
43
Prediction of quality traits and grades of intact chicken breast fillets by hyperspectral imaging. 61
32875810 2021
44
First Report of Cercospora Leaf Spot Caused by Cercospora cf. flagellaris on Okra in China. 61
33565890 2021
45
The NAD kinase Slr0400 functions as a growth repressor in Synechocystis sp. PCC 6803. 61
33560438 2021
46
Modelling flavour formation in roasted malt substrates under controlled conditions of time and temperature. 61
32781356 2021
47
Clear cell acanthoma. 61
32989899 2021
48
Hepatogenous photosensitization in ruminants and horses caused by the ingestion of Chamaecrista serpens in Brazil. 61
33516858 2021
49
Lesions associated with Bartonella taylorii-like bacterium infection in a free-ranging, young-of-the-year raccoon from Prince Edward Island, Canada. 61
33463406 2021
50
Scrotal Lymphangiectasia with Penile Elephantiasis in Underlying Lymphatic Filariasis-Challenging the Diagnostic Mind! A Case Report. 61
33401419 2021

Variations for Posttransplant Acute Limbic Encephalitis

Expression for Posttransplant Acute Limbic Encephalitis

Search GEO for disease gene expression data for Posttransplant Acute Limbic Encephalitis.

Pathways for Posttransplant Acute Limbic Encephalitis

GO Terms for Posttransplant Acute Limbic Encephalitis

Sources for Posttransplant Acute Limbic Encephalitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Mar-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....